Comparative Pharmacology
Head-to-head clinical analysis: E Z EM PREP LYTE versus E Z PREP 220.
Peer-Reviewed Evidence
Head-to-head clinical analysis: E Z EM PREP LYTE versus E Z PREP 220.
E-Z-EM PREP LYTE vs E-Z PREP 220
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Polyethylene glycol (PEG) 3350 is an osmotic laxative that induces diarrhea by retaining water in the bowel, thereby cleansing the colon. Electrolytes (sodium sulfate, sodium chloride, potassium chloride) are added to prevent electrolyte imbalance.
Bisacodyl is a diphenylmethane stimulant laxative that acts directly on colonic mucosa to stimulate sensory nerve endings, increasing peristalsis and colonic motility. It also inhibits water and electrolyte absorption in the small intestine and colon, leading to increased fluid accumulation and defecation.
Oral: 4 liters as a single dose for colonoscopy preparation.
Adult: 2.25 g (3 tablets of 750 mg each) orally, divided into two doses (1.5 g each) on the day before colonoscopy, with the second dose 6 hours before the procedure. Alternatively, 750 mg orally twice daily for 2 days prior. Route: oral. Frequency: as a split-dose or two-day regimen.
None Documented
None Documented
The terminal elimination half-life of PEG 3350 is approximately 4-6 hours; clinical effects are largely non-systemic due to minimal absorption.
Terminal elimination half-life: 24-36 hours (prolonged in renal impairment; no dose adjustment required for mild-moderate impairment but caution in severe forms).
Renal elimination of absorbed polyethylene glycol (PEG) is approximately 50-70% unchanged; the remainder is excreted in feces. Electrolytes are absorbed and renally excreted.
Renal: 60% as unchanged drug; Fecal: 30% (biliary elimination of glucuronide conjugates); Other: 10% metabolized via hepatic oxidation.
Category C
Category C
Bowel Prep (Polyethylene Glycol)
Bowel Prep (Polyethylene Glycol)